Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor

NCT01404650 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumor

Interventions

DRUG: AUY922

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]